News
India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback